XML 36 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Provision for Income Taxes (Tables)
12 Months Ended
Apr. 30, 2016
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The components of the provision (benefit) for income taxes are as follows (in thousands):
 
Year Ended April 30, 2016
 
Federal
 
State
 
Foreign
 
Total
Current
$

 
$

 
$
92

 
$
92

Deferred
(3,322
)
 
(537
)
 
11

 
(3,848
)
Change in valuation allowance
3,322

 
537

 
(11
)
 
3,848

 
 
 
 
 
 
 
 
Total
$

 
$

 
$
92

 
$
92

 
Year Ended April 30, 2015
 
Federal *
 
State *
 
Foreign
 
Total
Current
$

 
$
3

 
$
124

 
$
127

Deferred
(3,912
)
 
(287
)
 
8

 
(4,191
)
Change in valuation allowance
3,912

 
287

 
(8
)
 
4,191

 
 
 
 
 
 
 
 
Total
$

 
$
3

 
$
124

 
$
127


 
* The deferred and change in valuation allowance amounts for federal and state in the table above relating to the year ended April 30, 2015 were incorrectly presented in the previous filed 10-K on July 29, 2015 and have since been corrected herein. The incorrect disclosure had no impact on the total income tax expense or any other account balances of the Company's consolidated financial statements at April 30, 2015.
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation between the Company’s effective tax rate and the United States statutory tax rate for the years ended April 30, 2016 and 2015 is as follows:
 
Year Ended April 30,
 
2016
 
2015
Federal income tax at statutory rate
34.0
 %
 
34.0
 %
State income tax, net of federal benefit
3.1

 
2.6

Permanent differences
(0.2
)
 
0.9

Increase in uncertain tax position
(0.6
)
 
(0.8
)
Other
(2.2
)
 
(6.9
)
Change in valuation allowance
(37.2
)
 
(30.8
)
Changes in tax rates
2.2

 

 
 
 
 
Income tax expense
(0.9
)%
 
(1.0
)%
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company’s deferred tax assets and liabilities as of April 30, 2016 and 2015 consist of the following (in thousands):
 
As of April 30,
 
2016
 
2015
Accrued liabilities
$
21

 
$
21

State taxes
12

 
1

Stock-based compensation expense
5,528

 
4,803

Capitalized research and development costs
316

 
433

Foreign net operating loss carry-forward
224

 
235

Net operating loss carry-forward
12,970

 
9,719

 
 
 
 
Total deferred tax assets
19,071

 
15,212

Less: Valuation allowance
(19,071
)
 
(15,212
)
 
 
 
 
Net deferred tax asset
$

 
$

Schedule of Unrecognized Tax Benefits Roll Forward
The following table indicates the changes to the Company’s uncertain tax positions for the period and years ended April 30, 2016 and 2015 in thousands:
 
Year Ended April 30,
 
2016
 
2015
Balance, beginning of the year
$
100

 
$

Addition based on tax positions related to prior years
42

 
21

Addition based on tax positions related to current year
23

 
79

 
 
 
 
Balance, end of year
$
165

 
$
100